JCM Figure table search 04
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jauréguy, F.
Right arrow Articles by Doucet-Populaire, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jauréguy, F.
Right arrow Articles by Doucet-Populaire, F.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, November 2004, p. 5184-5188, Vol. 42, No. 11
0095-1137/04/$08.00+0     DOI: 10.1128/JCM.42.11.5184-5188.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.

Effects of Intrapartum Penicillin Prophylaxis on Intestinal Bacterial Colonization in Infants

Françoise Jauréguy,1,2,{dagger} Mathieu Carton,3 Pierre Panel,4 Pierre Foucaud,5 Marie-José Butel,1 and Florence Doucet-Populaire1,2*

Microbiologie, UFR des Sciences Pharmaceutiques et Biologiques, Université Paris 5, Paris,1 Microbiologie,2 Service de Gynécologie-Obstétrique,4 Service de Pédiatrie, Centre Hospitalier de Versailles, Le Chesnay,5 INSERM U88, St. Maurice, France3

Received 3 July 2004/ Returned for modification 22 July 2004/ Accepted 2 August 2004

Early-onset group B streptococcal (GBS) infections remain a leading cause of morbidity and mortality in infants. To prevent the vertical transmission of GBS and neonatal GBS infection, guidelines recommend intrapartum penicillin or amoxicillin prophylaxis. This intrapartum antibiotic prophylaxis (IAP) is suspected to favor colonization by antibiotic-resistant bacteria. However, the effects of this prophylaxis on the patterns of acquisition of gastrointestinal bacterial flora in infants have never been studied. We collected stool samples from 3-day-old infants born to mothers who received intrapartum amoxicillin (antibiotic-exposed group; n = 25) and to untreated mothers (non-antibiotic-exposed group; n = 25). The groups were matched for factors known to affect intestinal microbial colonization: gestational age, type of delivery, and type of feeding. Qualitative and quantitative differential analyses of the bacterial flora in stool samples were performed. Similar numbers of infants in the non-antibiotic-exposed and antibiotic-exposed groups were colonized by aerobic bacteria and amoxicillin-resistant enterobacteria (75 and 77%, respectively) (P = 0.79). In contrast, significantly fewer infants in the antibiotic-exposed group than in the non-antibiotic-exposed group were colonized by anaerobic bacteria, especially Clostridium (12 and 40%, respectively) (P < 0.05). Regarding intestinal bacterial colonization, the differences between antibiotic-exposed and non-antibiotic-exposed infants were remarkably few. The only statistically significant effect was the reduced initial bacterial colonization by Clostridium in the antibiotic-exposed group. In our study, the use of IAP did not favor colonization by ß-lactam-resistant bacteria. However, further evaluations are required to highlight the potential risks of the widespread use of antibiotics to prevent early-onset GBS infection.


* Corresponding author. Mailing address: Microbiologie, UFR des Sciences Pharmaceutiques et Biologiques, 4 Ave. de l'Observatoire, 75270 Paris Cedex 06, France. Phone: 33-1 53 73 99 13. Fax: 33-1 53 73 99 23. E-mail: florence.doucet-populaire{at}univ-paris5.fr.

{dagger} Present address: Service de Bactériologie-Virologie-Hygiène, Hôpital Avicenne, Université Paris 13, 125 Rt. de Stalingrad, 93009 Bobigny Cedex, France.


Journal of Clinical Microbiology, November 2004, p. 5184-5188, Vol. 42, No. 11
0095-1137/04/$08.00+0     DOI: 10.1128/JCM.42.11.5184-5188.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Antimicrob. Agents Chemother. Clin. Microbiol. Rev.
Clin. Vaccine Immunol. ALL ASM JOURNALS

Copyright © 2004 by the American Society for Microbiology. All rights reserved.